[junkie-button url=”http://infomeddnews.com/” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]
Musculoskeletal Transplant Foundation, the non-profit organization today announced it has changed its name to MTF Biologics.
The new name reflect how it has evolved over the last three decades from an organization started by orthopaedic surgeons to fill a need for high quality tissue to treat malignant bone tumors to an innovator in tissue regeneration serving a diverse range of healthcare providers and their patients.
“MTF Biologics has always operated at the intersection of science and compassion,” said Bruce Stroever, President and Chief Executive Officer at MTF Biologics. “We are committed to honoring tissue donors, serving patients and advancing science. While these core tenets of who we are will always be the same, our dedication to research and development continues to expand the ways we save and heal lives. Our new name reflects our legacy, how we have changed and how we will constantly strive to advance the science of tissue regeneration today and well into the future.”
Founded in 1987, MTF Biologics receives donated human tissue, such as skin, bone, tendons, ligaments, cartilage, and birth tissues, from donors throughout the country and processes and distributes it to the medical community to support and advance patient care. While the organization began with a focus on orthopaedic research, development and innovation, today its team of engineers, scientists and technicians work hand-in-hand with orthopaedic surgeons, plastic and reconstructive surgeons and wound healing specialists, among others, to develop new biologics that improve patient healing and outcomes.
Working with a national network of organ and tissue procurement agencies, MTF Biologics has received tissue from more than 120,000 donors and distributed more than 7.5 million grafts that have been used to treat orthopaedic oncology patients, repair damaged spines, heal burns, repair sports injuries, reconstruct breasts following mastectomy, and much more. It also has invested significantly in advancing the science of tissue regeneration. In addition to investments in its own research and development, MTF Biologics has provided more than $50 million in grant funding to fuel promising research at academic medical centers and research institutes across the nation.
The organization’s new name was intentionally chosen. “MTF” is a nod to its history and rich legacy of leadership in tissue science. “Biologics” underscores the tissues and products it develops and will continue to create, refine and advance.
“MTF Biologics is science-driven and patient-focused,” said Stroever. “Our team comes to work every day determined to help people around the world who are suffering because of accident, illness or injury. We take our responsibility to our patients and our physician partners very seriously, and our new name communicates that science is at the core of our work, but compassion is what drives it.”